Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged >=18 years; 2.Diagnosed with type 2 diabetes mellitus according to the diagnostic and classification criteria outlined in the "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)"; 3.LVEF >=50%; 4.Voluntarily signed informed consent form.
Exclusion criteria
Exclusion criteria: 1.Recent onset of acute diabetic complications, gestational diabetes, pregnancy, breastfeeding women. 2.Acute coronary syndrome, congenital heart disease, atrial fibrillation, severe valvular heart disease. 3.Acute and chronic infectious diseases, cancer. 4.Deemed unsuitable for participation in this study based on the investigator's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Triglyceride-Glucose and Visceral Fat Area index(TyG-VFA);left ventricular global longitudinal strain(LVGLS);Fasting blood glucose;Homeostasis Model Assessment 2 of Insulin Resistance;Triglyceride-Glucose-Visceral/Subcutaneous Fat Area; | — |
Secondary
| Measure | Time frame |
|---|---|
| Age;Gender;Height;Weight;Diabetes duration;Fasting C-peptide;HbA1c;Creatinine;Homocysteine;Triglyceride;Low-density lipoprotein;High-density lipoprotein;Cholesterol;Insulin-like growth factor 1;Left Atrial Diameter;Left ventricular end-diastolic diameter;Interventricular Septum;Ejection fraction;Triglyceride-Glucose index;Estimated glomerular filtration rate;Body Mass Index;Triglyceride-Glucose-Body Mass Index;Visceral Fat Area;Subcutaneous Fat Area; | — |
Countries
China
Contacts
Shenzhen Hospital, Southern Medical University